Jl. Szarek et al., SENSORY NERVE-MEDIATED AND NEUROPEPTIDE-MEDIATED RELAXATION RESPONSESIN AIRWAYS OF SPRAGUE-DAWLEY RATS, Journal of applied physiology, 78(5), 1995, pp. 1679-1687
We examined the role of sensory nerves in mediating nonadrenergic inhi
bitory responses in airway segments isolated from male Sprague-Dawley
rats. In the presence of adrenergic blockade, capsaicin (Cap; 1 mu M)
elicited marked relaxation responses in isolated bronchi precontracted
with bethanechol (Beth). Cap-induced inhibitory responses were unaffe
cted by tetrodotoxin (TTX), were attenuated by incubation of the airwa
y with indomethacin (Indo), phosphoramidon, or RP-67580, but were abol
ished by previous exposure of the airway to Cap and by denuding the ep
ithelium. Substance P (SP; 1 mu M), neurokinins A and B (1 mu M), and
calcitonin gene-related peptide (0.1 mu M) relaxed Beth-contracted air
way segments to a similar extent. The SP-induced responses were unaffe
cted by adrenergic blockade or by pretreatment with either TTX, phosph
oramidon, or Cap, but were attenuated by RP-67580 and abolished by Ind
o and by denuding the epithelium. In anesthetized mechanically ventila
ted rats, Cap (50 and 100 mu g/kg iv) elicited a dose-dependent revers
al of the increase in lung resistance induced by an infusion of Beth.
The Cap-induced bronchodilation was unaffected by pretreatment with pr
opranolol alone or in combination with hexamethonium. SP (44 nmol/kg i
v) also evoked bronchodilatory responses in intact animals, which were
unaffected by propranolol and hexamethonium but were abolished by tre
atment of the animals with Indo. Electrical-field stimulation (EFS) ev
oked nonadrenergic noncholinergic relaxation responses in contracted a
irway segments. These EFS-induced inhibitory responses were markedly a
ttenuated by treatment of the airway segment with TTX, Cap, or RP-6758
0. We conclude that neuropeptides released from Cap-sensitive sensory
nerves have potent inhibitory effects in rat airways that are mediated
, in part, by activation of neurokonin NK1 receptors on epithelium and
subsequent release of an inhibitory prostaglandin(s).